CTEP

Results: 314



#Item
231Save As  Print Form Next Page

Save As Print Form Next Page

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2013-05-06 19:22:24
232Pharmaceutical Management Branch * Cancer Therapy Evaluation Program * Division of Cancer Treatment and Diagnosis * National Cancer Institute 6130 Executive Blvd * Suite 7149 * Rockville, Maryland 20852 * Phone: ([removed]

Pharmaceutical Management Branch * Cancer Therapy Evaluation Program * Division of Cancer Treatment and Diagnosis * National Cancer Institute 6130 Executive Blvd * Suite 7149 * Rockville, Maryland 20852 * Phone: ([removed]

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2008-05-28 21:39:37
233Nursing research / Epidemiology / Cancer organizations / Pharmacology / Biomarker / National Cancer Institute / Clinical trial / National Institutes of Health / Imaging biomarker / Medicine / Biology / Health

DOC Document

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2013-08-06 21:14:13
234Brief Overview of Key Information for Funding Opportunity Announcements (FOAs) under the NCTN Program - As of July 23, 2012  FOA Number (Activity Code)  RFA-CA[removed]

Brief Overview of Key Information for Funding Opportunity Announcements (FOAs) under the NCTN Program - As of July 23, 2012 FOA Number (Activity Code) RFA-CA[removed]

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2014-02-13 18:55:36
235TGF 1 - Early Player in Mouse Colon Cancer: Suppresses IBD-Associated Colon Cancer by Preventing Pre-Clinical Inflammatory State of Readiness in Colon Mucosal Epithelium Thomas Doetschman BIO5 Institute, University of Ar

TGF 1 - Early Player in Mouse Colon Cancer: Suppresses IBD-Associated Colon Cancer by Preventing Pre-Clinical Inflammatory State of Readiness in Colon Mucosal Epithelium Thomas Doetschman BIO5 Institute, University of Ar

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2014-02-13 18:55:37
236Expression Profiling in High Risk ALL: New Insights for Therapy and Novel Therapeutic Target Identification NCI Meeting: Unique Characteristics of AYA Cancers June 9-10, 2009 NCI CA114762 Strategic Partnerships to Evalua

Expression Profiling in High Risk ALL: New Insights for Therapy and Novel Therapeutic Target Identification NCI Meeting: Unique Characteristics of AYA Cancers June 9-10, 2009 NCI CA114762 Strategic Partnerships to Evalua

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2014-02-13 18:55:37
237Treatment of Adolescents and Young Adults with ALL with an Asparaginase-Intensive Pediatric Regimen Lewis Silverman, M.D. Dana-Farber Cancer Institute

Treatment of Adolescents and Young Adults with ALL with an Asparaginase-Intensive Pediatric Regimen Lewis Silverman, M.D. Dana-Farber Cancer Institute

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2014-02-13 18:55:38
238

PDF Document

Add to Reading List

Source URL: ctep.cancer.gov

- Date: 2010-10-27 22:09:14
    239   CTEP DISTRICT LIAISON   PERFORMANCE  GUIDELINES

      CTEP DISTRICT LIAISON   PERFORMANCE  GUIDELINES

    Add to Reading List

    Source URL: www.mdt.mt.gov

    Language: English - Date: 2011-09-28 09:18:31
    240Colorectal Carcinoma in Children and Adolescents Review of 77 patients from St. Jude Analysis in progress  D. Ashley Hill, M.D.

    Colorectal Carcinoma in Children and Adolescents Review of 77 patients from St. Jude Analysis in progress D. Ashley Hill, M.D.

    Add to Reading List

    Source URL: ctep.cancer.gov

    Language: English - Date: 2014-02-13 18:55:37